Home › Trial NCT00264433
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
- Trial IDNCT00264433
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAdherex Technologies, Inc.
- Enrollment—
- Start date—
- ConditionsNeoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.